Ionis Pharmaceuticals | IONS - Należności Handlowe





Należności Handlowe Zmiana Data
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Astellas Pharma JPY 761.76B 48.47B 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Exelixis USD 286.92M 24.38M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
OPKO Health USD 126.12M 1.74M 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 18.12B 2.02B 2025-09
Pharma Mar EUR 60.6M 18.83M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09